Stock Information
Royalty Pharma PLC (RPRX)
Ticker Symbol: RPRX
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $28,036.45 mil
Piotroski score: 5
PE Ratio: 36.4427
EPS (TTM): 1.3652
Revenue (TTM): $4.27 M
Dividend Yield: 1.9301848049281%
ROE: 11.89%
Latest News
-
Royalty Pharma : Q1 2026 Pre-Quarterly Results Communication
Wed, Apr 15, 2026 4:38 PM
-
Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
Wed, Apr 15, 2026 4:15 PM
-
Royalty Pharma : 2025 Corporate Responsibility Report pdf
Tue, Apr 14, 2026 4:30 PM
-
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside
Mon, Apr 13, 2026 12:35 PM
-
Morgan Stanley Maintains Overweight on Royalty Pharma, Raises Price Target to $63
Fri, Apr 10, 2026 11:54 AM
Key Financials
Financial data not available
